Benfotiamine
C19H23N4O6PS — CID 3032771
View drug profile → benfotiamineData last refreshed: (MolForge compound catalog, from PubChem)
About Benfotiamine
Benfotiamine (PubChem CID 3032771) has the molecular formula C19H23N4O6PS and a molecular weight of 466.46 g/mol. Its IUPAC name is S-[(Z)-2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-phosphonooxypent-2-en-3-yl] benzenecarbothioate.
Molecular Properties
| Compound Name | Benfotiamine |
|---|---|
| PubChem CID | 3032771 |
| Molecular Formula | C19H23N4O6PS |
| Molecular Weight | 466.46 g/mol |
| Exact Mass | 466.11 |
| IUPAC Name | S-[(Z)-2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-phosphonooxypent-2-en-3-yl] benzenecarbothioate |
| SMILES | C/C(=C(\CCOP(=O)(O)O)SC(=O)c1ccccc1)N(C=O)Cc1cnc(C)nc1N |
| InChI | InChI=1S/C19H23N4O6PS/c1-13(23(12-24)11-16-10-21-14(2)22-18(16)20)17(8-9-29-30(26,27)28)31-19(25)15-6-4-3-5-7-15/h3-7,10,12H,8-9,11H2,1-2H3,(H2,20,21,22)(H2,26,27,28)/b17-13- |
| InChIKey | BTNNPSLJPBRMLZ-LGMDPLHJSA-N |
| XLogP | 2.63 |
| TPSA | 155.94 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 466.46 |
| LogP ≤ 5 | 2.63 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'thioester', 'substructure': 'N/A'} |
|---|
Related Compounds
Frequently Asked Questions
Browse: Molecules: B · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 3032771 — identifiers, structure, computed properties (public domain)
- DrugCentral drug card 308 — approved-drug record (CC BY-SA 4.0)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.